nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating drug discovery
|
Goldman, Mark E. |
|
1997 |
2 |
9 |
p. 357-358 2 p. |
artikel |
2 |
Development of an automated high-throughput screening system: a case history
|
Harding, David |
|
1997 |
2 |
9 |
p. 385-390 6 p. |
artikel |
3 |
Emerging molecular targets
|
Wallace, Robert W. |
|
1997 |
2 |
9 |
p. 396- 1 p. |
artikel |
4 |
Hard graft and ‘hoopla’ — ACS highlights
|
Williams, John P. |
|
1997 |
2 |
9 |
p. 362-364 3 p. |
artikel |
5 |
High-throughput screening
|
Rogers, Mark V. |
|
1997 |
2 |
9 |
p. 395-396 2 p. |
artikel |
6 |
Monitor: molecules and profiles
|
Terrett, Nick |
|
1997 |
2 |
9 |
p. 391-394 4 p. |
artikel |
7 |
[No title]
|
Murcko, Mark A. |
|
1997 |
2 |
9 |
p. 364- 1 p. |
artikel |
8 |
Pharmaceutical innovation between scientific opportunities and economic constraints
|
Drews, Jürgen |
|
1997 |
2 |
9 |
p. 365-372 8 p. |
artikel |
9 |
Reactive compounds and in vitro false positives in HTS
|
Rishton, Gilbert M. |
|
1997 |
2 |
9 |
p. 382-384 3 p. |
artikel |
10 |
Society for biomolecular screening — origin and future role
|
Fernandes, Prabhavathi B. |
|
1997 |
2 |
9 |
p. 361- 1 p. |
artikel |
11 |
Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications
|
Hemmilä, Ilkka |
|
1997 |
2 |
9 |
p. 373-381 9 p. |
artikel |
12 |
What's your poison?
|
Wallace, Robert W. |
|
1997 |
2 |
9 |
p. 359-361 3 p. |
artikel |